Hai‐Bin Shi
- Epidemiology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Neurology top 2%
- Surgery top 10%
- Topics
- Acute Ischemic Stroke Management (70 papers)Cerebrovascular and Carotid Artery Diseases (54 papers)Venous Thromboembolism Diagnosis and Management (31 papers)
- Cited by
- HepatologyInternal MedicineNeurology
- Journals
- Journal of Biological ChemistrySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hai‐Bin Shi
202 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 103
- Epidemiology 793
- Pulmonary and Respiratory Medicine 787
- Radiology, Nuclear Medicine and Imaging 672
- Neurology 502
- Surgery 413
Countries citing papers authored by Hai‐Bin Shi
This map shows the geographic impact of Hai‐Bin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai‐Bin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai‐Bin Shi more than expected).
Fields of papers citing papers by Hai‐Bin Shi
This network shows the impact of papers produced by Hai‐Bin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai‐Bin Shi. The network helps show where Hai‐Bin Shi may publish in the future.
Co-authorship network of co-authors of Hai‐Bin Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Hai‐Bin Shi. A scholar is included among the top collaborators of Hai‐Bin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai‐Bin Shi. Hai‐Bin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 5 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 10 | |
| 14 | Safety and Efficacy of Transarterial Chemoembolization and Immune Checkpoint Inhibition with Camrelizumab for Treatment of Unresectable Hepatocellular Carcinoma | 22 |
| 15 | 8 | |
| 16 | 10 | |
| 17 | 1 | |
| 18 | 7 | |
| 19 | 3 | |
| 20 | 16 |
About Hai‐Bin Shi
Hai‐Bin Shi is a scholar working on Internal Medicine, Hepatology and Neurology, having authored 212 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (70 papers), Cerebrovascular and Carotid Artery Diseases (54 papers) and Venous Thromboembolism Diagnosis and Management (31 papers). The work is most often cited by research in Hepatology (411 citations), Internal Medicine (160 citations) and Neurology (502 citations). Hai‐Bin Shi has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Sheng Liu, Xiao‐Quan Xu, Qing‐Quan Zu, Shanshan Lu, Lin‐Bo Zhao, Hao Hu, Zhenyu Jia, Chun‐Gao Zhou, Chen‐Jiang Wu and Yu‐Dong Zhang. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.